Document is current
Any future updates will be listed below
-
Authors
Marshall, Jean S.
Upton, Julia E. M.
Vliagoftis, Harissios
Hildebrand, Kyla J.
Byrne, Adam
Watson, Wade
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 15 November 2024
First Online: 19 December 2024
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Jean S. Marshall, Dr. Harissios Vliagoftis and Dr. Wade Watson are Associate Editors of <i>Allergy Asthma and Clinical Immunology</i>. Dr. Wade Watson is also medical advisor to Food Allergy Canada. Dr. Julia Upton is a medical advisory board member of Immunodeficiency Canada, a member of the Board of Directors for the Canadian Society of Allergy and Clinical Immunology, and clinical trial investigator for Sanofi/Regeneron, ALK-Abello and DBV Technologies; she has received research support from Novartis, unrestricted educational honorarium from Astra Zeneca, and has participated as a scientific advisory board member for Pharming Group N.V. and Pfizer. Dr. Kyla Hildebrand and Dr. Adam Byrne have no competing interests to disclose. None of the authors received any incentive or funding for the preparation or review of the manuscript.
